TY  - GEN
AU  - Tong,Gary
AU  - Wang,Jun-Sheng
AU  - Sverdlov,Oleksandr
AU  - Huang,Shu-Pang
AU  - Slemmon,Randy
AU  - Croop,Robert
AU  - Castaneda,Lorna
AU  - Gu,Huidong
AU  - Wong,Oi
AU  - Li,Hewei
AU  - Berman,Robert M
AU  - Smith,Christina
AU  - Albright,Charles F
AU  - Dockens,Randy
TI  - A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ-secretase inhibitor avagacestat
SN  - 1365-2125
PY  - 2013///0805
KW  - Administration, Oral
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Alzheimer Disease
KW  - drug therapy
KW  - Amyloid Precursor Protein Secretases
KW  - antagonists & inhibitors
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Oxadiazoles
KW  - adverse effects
KW  - Sulfonamides
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1365-2125.2012.04339.x
ER  -